Pliant Therapeutics, Inc.
US ˙ NasdaqGS ˙ US7291391057

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for David E I Pyott. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at David E I Pyott har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ALNY / Alnylam Pharmaceuticals, Inc. Director 911
US:BMRN / BioMarin Pharmaceutical Inc. Director 49.750
US:PLRX / Pliant Therapeutics, Inc. Director 13.286
US:AVY / Avery Dennison Corporation Director 0
Chairman of the Board and CEO, Director 0
US:EW / Edwards Lifesciences Corporation Director 1.874
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af David E I Pyott. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb PLRX / Pliant Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PLRX / Pliant Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PLRX / Pliant Therapeutics, Inc. Insider Trades
Insidersalg PLRX / Pliant Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PLRX / Pliant Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PLRX / Pliant Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af David E I Pyott som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-05-12 2025-05-08 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 775 911 569,85
2025-03-25 2025-03-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.440 136 -98,20 299,00 -2.224.560 40.664
2025-03-25 2025-03-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7.440 7.576 5.470,59 88,95 661.788 673.885
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.470 136 -98,21 222,00 -1.658.340 30.192
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.420 7.606 -49,38 221,00 -1.639.820 1.680.926
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -17.560 15.026 -53,89 220,00 -3.863.200 3.305.720
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7.470 32.586 29,74 71,99 537.765 2.345.866
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7.420 25.116 41,93 70,20 520.884 1.763.143
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 17.560 17.696 12.911,76 88,95 1.561.962 1.574.059
2024-05-23 2024-05-21 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4.720 49.750 10,48
2023-05-24 2023-05-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4.190 45.030 10,26
2023-02-27 2023-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 136 136
2022-05-26 2022-05-24 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4.980 40.840 13,89
2022-05-20 2022-05-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 5.153 5.153
2022-02-25 2022-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 136 136
2021-07-19 2021-07-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.032 4.032
2021-07-01 2021-06-29 4/A PLRX PLIANT THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 13.286 13.286
2021-06-30 2021-06-29 4 PLRX PLIANT THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 13.286 13.286
2021-05-27 2021-05-25 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 5.120 35.860 16,66
2021-01-13 2021-01-12 4 PLRX PLIANT THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 26.573 26.573
2020-09-01 2020-08-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
P - Purchase 900 30.740 3,02 78,84 70.955 2.423.520
2020-09-01 2020-08-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
P - Purchase 11.900 29.840 66,33 78,22 930.760 2.333.939
2020-07-06 2020-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.581 4.581
2020-05-29 2020-05-27 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4.300 17.940 31,52
2020-04-24 2020-04-23 4 AVY Avery Dennison Corp
2019 Director RSU Award
M - Exercise -1.414 0 -100,00
2020-04-24 2020-04-23 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1.414 18.684 8,19 107,56 152.090 2.009.651
2020-02-05 2020-02-03 4 AVY Avery Dennison Corp
2010 Director Stock Option
M - Exercise -5.027 0 -100,00
2020-02-05 2020-02-03 4 AVY Avery Dennison Corp
Common Stock
S - Sale -5.027 17.270 -22,55 132,72 -667.183 2.292.074
2020-02-05 2020-02-03 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 5.027 22.297 29,11 38,18 191.931 851.299
2019-07-02 2019-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9.000 9.000
2019-06-06 2019-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4.430 13.640 48,10
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
2019 Director RSU Award
A - Award 1.414 1.414
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
2018 Director RSU Award
M - Exercise -1.336 0 -100,00
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
M - Exercise -641 0 -100,00
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1.336 17.270 8,38 109,63 146.466 1.893.310
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 641 15.934 4,19 109,63 70.273 1.746.844
2018-11-28 2018-11-27 4 AVY Avery Dennison Corp
2009 Director Stock Option
M - Exercise -2.000 0 -100,00
2018-11-28 2018-11-27 4 AVY Avery Dennison Corp
Common Stock
S - Sale -2.000 15.293 -11,57 93,00 -186.000 1.422.249
2018-11-28 2018-11-27 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 2.000 17.293 13,08 20,64 41.280 356.928
2018-06-22 2018-06-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9.000 9.000
2018-06-07 2018-06-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4.300 9.210 87,58
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2018 Director RSU Award
A - Award 1.336 1.336
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2017 Director RSU Award
M - Exercise -1.678 0 -100,00
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
M - Exercise -641 641 -50,00
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2015 Director RSU Award
M - Exercise -747 0 -100,00
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1.678 15.293 12,32 104,80 175.854 1.602.706
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 641 13.615 4,94 104,80 67.177 1.426.852
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 747 12.974 6,11 104,80 78.286 1.359.675
2017-08-30 2017-08-30 4 AVY Avery Dennison Corp
2008 Director Stock Option
M - Exercise -1.702 0 -100,00
2017-08-30 2017-08-30 4 AVY Avery Dennison Corp
Common Stock
S - Sale -1.702 16.303 -9,45 94,00 -159.988 1.532.482
2017-08-30 2017-08-30 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1.702 18.005 10,44 52,12 88.700 938.331
2017-08-30 2017-08-28 4 AVY Avery Dennison Corp
2008 Director Stock Option
M - Exercise -298 1.702 -14,90
2017-08-30 2017-08-28 4 AVY Avery Dennison Corp
Common Stock
S - Sale -298 16.303 -1,80 94,00 -28.012 1.532.482
2017-08-30 2017-08-28 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 298 16.601 1,83 52,12 15.530 865.161
2017-06-08 2017-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 4.910 4.910
2017-06-08 2017-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 2.050 4.910 71,68
2017-06-06 2017-06-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11.250 11.250
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2017 Director RSU Award
A - Award 1.678 1.678
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
M - Exercise -640 1.282 -33,30
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2015 Director RSU Award
M - Exercise -746 747 -49,97
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2014 Director RSU Award
M - Exercise -859 0 -100,00
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 640 16.303 4,09 83,42 53.389 1.359.996
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 746 15.663 5,00 83,42 62.231 1.306.607
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 859 14.917 6,11 83,42 71.658 1.244.376
2016-10-14 2016-10-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 27.900 27.900 37,00 1.032.328 1.032.328
2016-08-09 2016-08-08 4 AVY Avery Dennison Corp
2006 Director Stock Option
M - Exercise -2.000 0 -100,00
2016-08-09 2016-08-08 4 AVY Avery Dennison Corp
Common Stock
S - Sale -2.000 14.058 -12,45 78,61 -157.220 1.105.099
2016-08-09 2016-08-08 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 2.000 16.058 14,23 67,80 135.590 1.088.652
2016-06-08 2016-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 2.220 2.220
2016-06-08 2016-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 760 2.860 36,19
2016-06-07 2016-06-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11.250 11.250
2016-05-02 2016-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
A - Award 1.922 1.922
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
2015 Director RSU Award
M - Exercise -746 1.493 -33,32
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
2014 Director RSU Award
M - Exercise -859 859 -50,00
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
2013 Director RSU Award
M - Exercise -1.015 0 -100,00
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 746 14.058 5,60 72,82 54.324 1.023.704
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 859 13.312 6,90 72,82 62.552 969.380
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1.015 12.453 8,87 72,82 73.912 906.827
2016-01-06 2016-01-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 6.100 6.100
2016-01-06 2016-01-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 2.100 2.100
2015-12-22 2015-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25.000 25.000
2015-11-03 2015-11-02 4 AVY Avery Dennison Corp
2005 Director Stock Option
M - Exercise -2.000 0 -100,00
2015-11-03 2015-11-02 4 AVY Avery Dennison Corp
Common Stock
S - Sale -2.000 11.438 -14,88 64,88 -129.760 742.097
2015-11-03 2015-11-02 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 2.000 13.438 17,49 59,46 118.930 799.091
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
2015 Director RSU Award
A - Award 2.239 2.239
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
2014 Director RSU Award
M - Exercise -859 1.718 -33,33
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
2013 Director RSU Award
M - Exercise -1.015 1.015 -50,00
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 859 11.438 8,12 55,84 47.967 638.698
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1.015 10.579 10,61 55,84 56.678 590.731
2015-04-28 2015-04-26 4 AVY Avery Dennison Corp
2012 Director Rsu Award
M - Exercise -524 0 -100,00
2015-04-28 2015-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 524 9.564 5,80 51,77 27.127 495.128
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -257.756 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -422.400 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -303.000 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -533.000 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -312.000 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -375.000 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -410.000 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -386.800 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -114.548 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -2.897 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -2.180 0 -100,00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -165.658 0 -100,00
2015-03-19 2015-02-12 4 AGN ALLERGAN INC
Common Stock
G - Gift -114.548 114.548 -50,00
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Restricted Stock Units
M - Exercise -1.379 0 -100,00
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Restricted Stock Units
A - Award 1.379 1.379
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Common Stock
F - Taxes -720 165.659 -0,43 234,00 -168.480 38.764.206
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Common Stock
M - Exercise 1.379 166.379 0,84
2014-12-02 2014-12-01 4 AVY Avery Dennison Corp
Common Stock Units - DDECP
A - Award 1.119 39.412 2,92
2014-05-13 2014-05-09 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 1.874 1.874
2014-05-13 2014-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2.342 53.582 4,57
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
2013 Director RSU Award
M - Exercise -1.015 2.030 -33,33
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
Common Stock Units - DDECP
A - Award 1.289 37.754 3,54
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
2014 Director RSU Award
A - Award 2.577 2.577
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1.015 9.040 12,65 48,50 49.228 438.440
2014-04-29 2014-04-28 4 AVY Avery Dennison Corp
2011 Director RSU
M - Exercise -391 0 -100,00
2014-04-29 2014-04-28 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 391 8.025 5,12 48,82 19.089 391.780
2014-04-29 2014-04-26 4 AVY Avery Dennison Corp
2012 Director RSU Award
M - Exercise -523 524 -49,95
2014-04-29 2014-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 523 7.634 7,35 48,70 25.473 371.814
2014-02-25 2014-02-21 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
A - Award 257.756 257.756 125,07 32.237.543 32.237.543
2014-02-13 2014-02-12 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -252.000 0 -100,00
2014-02-13 2014-02-12 4 AGN ALLERGAN INC
Common Stock
S - Sale -252.000 165.000 -60,43 123,12 -31.025.560 20.314.354
2014-02-13 2014-02-12 4 AGN ALLERGAN INC
Common Stock
M - Exercise 252.000 417.000 152,73 36,15 9.109.800 15.074.550
2013-12-03 2013-12-01 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1.278 36.046 3,68
2013-05-17 2013-05-15 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 2.250 2.250
2013-05-17 2013-05-15 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2.811 51.240 5,80
2013-05-02 2013-05-01 4 AVY Avery Dennison Corp
2013 Director RSU Award
A - Award 3.045 3.045
2013-05-02 2013-05-01 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 774 34.313 2,31
2013-05-01 2013-05-01 4 EW Edwards Lifesciences Corp
Common Stock
P - Purchase 3.000 48.429 6,60 62,95 188.850 3.048.606
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
2012 Director RSU
M - Exercise -522 1.047 -33,27
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
2011 Director RSU
M - Exercise -390 391 -49,94
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 522 7.111 7,92 41,52 21.671 295.213
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 390 6.589 6,29 41,52 16.191 273.542
2013-04-23 2013-04-22 4 AVY Avery Dennison Corp
2010 Director RSU
M - Exercise -436 0 -100,00
2013-04-23 2013-04-22 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 436 6.199 7,57 40,85 17.811 253.229
2013-04-02 2013-04-01 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 983 33.539 3,02
2013-02-22 2013-02-21 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
A - Award 303.000 303.000
2012-12-20 2012-12-19 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1.233 32.556 3,94
2012-10-05 2012-10-05 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -307.956 0 -100,00
2012-10-05 2012-10-05 4 AGN ALLERGAN INC
Common Stock
S - Sale X -307.956 229.096 -57,34 93,72 -28.862.868 21.471.794
2012-10-05 2012-10-05 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 307.956 537.052 134,42 41,24 12.700.105 22.148.024
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -101.421 307.956 -24,77
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -90.623 409.377 -18,12
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -119.000 0 -100,00
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
S - Sale X -101.421 229.096 -30,69 93,71 -9.504.486 21.469.319
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 101.421 330.517 44,27 41,24 4.182.602 13.630.521
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 90.623 229.096 65,44 41,24 3.737.293 9.447.919
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 119.000 138.473 611,10 30,12 3.584.875 4.171.499
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
S - Sale X -206.923 19.473 -91,40 93,74 -19.396.714 1.825.376
2012-10-05 2012-09-21 4 AGN ALLERGAN INC
Common Stock
G - Gift 19.473 226.396 9,41
2012-10-05 2012-09-21 4 AGN ALLERGAN INC
Common Stock
G - Gift -19.473 165.000 -10,56
2012-10-02 2012-09-28 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1.179 31.323 3,91
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise -3.520 0 -100,00
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise -3.278 0 -100,00
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Common Stock
S - Sale -6.798 45.429 -13,02 100,65 -684.199 4.572.297
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise 3.278 52.227 6,70 24,42 80.049 1.275.383
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise 3.520 48.949 7,75 22,72 79.957 1.111.877
2012-07-02 2012-06-29 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1.304 30.144 4,52
2012-05-18 2012-05-16 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
G - Gift 312.000 312.000
2012-05-18 2012-05-16 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
G - Gift -312.000 0 -100,00
2012-05-14 2012-05-11 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 1.890 1.890
2012-05-14 2012-05-11 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2.361 45.429 5,48
2012-04-30 2012-04-27 4 AVY Avery Dennison Corp
2011 Director RSU
M - Exercise -389 781 -33,25
2012-04-30 2012-04-27 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 389 5.763 7,24 32,36 12.586 186.462
2012-04-30 2012-04-26 4 AVY Avery Dennison Corp
2012 Director Stock Option
A - Award 6.318 6.318
2012-04-30 2012-04-26 4 AVY Avery Dennison Corp
2012 Director RSU Award
A - Award 1.569 1.569
2012-04-23 2012-04-20 4 AVY Avery Dennison Corp
2010 Director RSU
M - Exercise -437 436 -50,06
2012-04-23 2012-04-20 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 437 5.374 8,85 31,33 13.691 168.367
2012-04-02 2012-03-30 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1.338 28.840 4,86
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
A - Award 312.000 312.000
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Common Stock
A - Award 2.045 185.563 1,11
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Common Stock
F - Taxes -955 183.518 -0,52 87,91 -83.954 16.133.067
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Common Stock
A - Award 165.000 184.473 847,33
2012-02-16 2012-02-14 4 AGN ALLERGAN INC
Common Stock
F - Taxes -12.869 18.383 -41,18 88,10 -1.133.823 1.619.634
2012-01-18 2012-01-18 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise X -20.000 0 -100,00
2012-01-18 2012-01-18 4 EW Edwards Lifesciences Corp
Common Stock
S - Sale X -20.000 43.068 -31,71 76,95 -1.539.060 3.314.212
2012-01-18 2012-01-18 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise X 20.000 63.068 46,44 12,88 257.700 812.631
2010-05-18 2010-05-14 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 796 796
2010-05-18 2010-05-14 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1.987 29.286 7,28
2004-05-17 2004-05-13 4 EW EDWARDS LIFESCIENCES CORP
Common Stock
A - Award 4.000 9.000 80,00
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)